Bloating is a common digestive issue affecting people of all ages, however, the experience becomes more frequent and severe ...

Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...

Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...

Itolizumab demonstrated clinical efficacy after 12 weeks of treatment, achieving a clinical remission rate of 23.3% compared to 20.0% for adalimumab and 10.0% ...

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

Teddy Swims is elated about 2 babies Teddy Swims is busier than ever with two babies on the way: The child he’s expecting, ...

Chloe Sargent went through a period of grief after being diagnosed with Crohn's disease in 2010.

Left to right - Dr. Riccardo Rampado & Prof. Dan Peer. Researchers at Tel Aviv University have achieved a breakthrough in ...

Cloves have antimicrobial and antifungal properties that help protect the gut from harmful bacteria and parasites. They also ...

These conditions are commonly misdiagnosed for anxiety when they are really something far more serious than that ...

I’m pretty sure I saw stars in her eyes as she summarized her privilege to serve in the Congress as a U.S. Senator in those storied halls. It’s where the likes of “U.S. Senator and 35th President John ...